| |
Totala
|
TB-HIV
|
HIV
|
p-value
|
|---|
|
(n = 32)
|
(n = 17)
|
(n = 15)
|
|---|
|
Female
|
62% (20/32)
|
47% (8/17)
|
80% (12/15)
|
0.08^
|
|
Median Age (range)
|
32 [18–53]
|
30 [18–52]
|
36 [24–53]
|
0.43^^
|
|
Initial CD4+ (cells/μL)
|
50 [4–105]b
|
23 [4–105]
|
67 [11–96]
|
0.15^^
|
|
Time to ART start (days)
|
14 [6–80]c
|
14.5 [12–80]
|
12 [6–51]
|
0.08^^
|
|
IRIS
|
20% (5/25)
|
45% (5/11)
|
0% (0/14)
|
0.13^
|
|
Alive at 6 months
|
75% (24/32)
|
59% (10/17)
|
93% (14/15)
|
0.03^
|
- aDemographic data available for 32 study participants. Whole blood RNA-Seq analysis done for 33 participants
- bThe initial CD4 count for 2 participants was 103 and 105 cells/μl; however when repeated for the study, the counts were less than 100 cells/μl
- c19 observations
- ^p-value calculated by Fischer’s exact
- ^^p-value calculated by Wilcoxon rank sum test
- Age given is median age, range is entire range of ages. CD4+ range is entire range of CD4+ T cell counts
